S1PR2 and cancer: Additionally, taurocholic acid TCA, a conjugated BA, was found to accelerate the growth of S1PR2-overexpressing pancreatic cancer both in vitro and in vivo, suggesting that S1PR2 may be a potential therapeutic target in cancer [188].